XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform
India News
Japan’s MHLW approves Daiichi Sankyo’s breast cancer treatment
The approval was based on findings from the Phase III DESTINY-Breast03 trial of Enhertu.
Xeris and Horizon enter partnership to develop teprotumumab
Biovac and IVI enter deal to develop oral cholera vaccine
EC grants approval for AbbVie’s Skyrizi to treat Crohn’s disease
EC approves Regeneron’s immunotherapy for cervical cancer
FDA grants approval for CSL’s haemophilia B gene therapy
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
